Oculogica

About:

Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.

Twitter/X: oculogica

Top Investors: Golden Seeds, TitletownTech, Colle Capital Partners, Daren Cotter, Sofia Fund

Description:

Oculogica is a medical device manufacturing company that specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye-tracking. The company's EyeBOX device is the only baseline-free test authorized by the FDA as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI). It requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will. Oculogica was established in 2013 and is based in New York, NY, United States.

Total Funding Amount:

$25.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)oculogica.com

Founders:

Robert Ritlop, Uzma Samadani

Number of Employees:

1-10

Last Funding Date:

2024-05-13

IPO Status:

Private

Industries: